-Q Ping Dou Researcher Activity Profile

Research Author Detailed Information 

Q Ping Dou Publication Rate By Year

Q Ping Dou has published 3 paper(s) in 2006, 10 paper(s) in 2007, 1 paper(s) in 2008, for a total of 14 research publications in total.

Q Ping Qp Dou Author Information

LAST NAME: dou

FIRST NAME: Q Ping

INITIALS: qp

AFFILIATION:

Papers

Q Ping Dou's Publication Record

1. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.
2. Lessons learned from Art Pardee in cell cycle, science, and life. Year Published: 2006
The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Department of Pathology, School of Medicine, Wayne State University, 4100 John R. Road, Detroit, MI 48201, USA. doup@karmanos.org
3. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells. Year Published: 2006
The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
4. Calmodulin-androgen receptor (AR) interaction: calcium-dependent, calpain-mediated breakdown of AR in LNCaP prostate cancer cells. Year Published: 2006
Vattikuti Urology Institute and Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA.
5. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry". Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Department of Pathology, School of Medicine, Wayne State University, 640.1 HWCRC, 4100 John R Road, Detroit, MI 48201, USA.
6. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. Year Published: 2007
Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
7. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. Year Published: 2007
Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
8. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Year Published: 2007
Department of Hematology/Oncology, Henry Ford Hospital, MI 458202, USA.
9. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.
10. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.
11. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, Department of Pathology, School of Medicine, Wayne State University, Detroit, MI 48201-2013, USA.
12. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, Michigan.
13. Tea polyphenols, their biological effects and potential molecular targets. Year Published: 2008
The Prevention Program, Barbara Ann Karmanos Cancer Institute and Department of Pathology, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.
14. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. Year Published: 2007
The Prevention Program, Barbara Ann Karmanos Cancer Institute, School of Medicine, Wayne State University, Detroit, Michigan, USA.